يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Pierre-Marie Gonnaud"', وقت الاستعلام: 0.62s تنقيح النتائج
  1. 1
    Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

    المؤلفون: Jean-Yves Hogrel, Daniel Tanesse, Laurence Attolini, Eric Azabou, Tanya Stojkovic, Rafaëlle Bernard, Odile Dubourg, Marie-Noëlle Lefebvre, Michel Fontes, Mahmoud Al-Moussawi, Shahram Attarian, Olivier Blin, Elisabeth Jouve, Pierre-Marie Gonnaud, Jean Pouget, Francois Vacherot, Jean-Francois Remec, Sadek Yaici, Joëlle Micallef, Severine Pitel, Laurent Jomir

    المصدر: The Lancet Neurology. 8:1103-1110

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Movement, Sensation, Placebo-controlled study, Physical examination, Ascorbic Acid, Walking, Placebo, Antioxidants, law.invention, Random Allocation, Double-Blind Method, Randomized controlled trial, Charcot-Marie-Tooth Disease, law, Internal medicine, medicine, Humans, Muscle Strength, Adverse effect, Intention-to-treat analysis, Hand Strength, medicine.diagnostic_test, business.industry, Middle Aged, Ascorbic acid, Muscle atrophy, Surgery, Treatment Outcome, Socioeconomic Factors, Female, Neurology (clinical), medicine.symptom, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192f9b483a6b5c3ee67c715c170b6b39Test
    https://doi.org/10.1016/s1474-4422Test(09)70260-1


    أضف إلى المفضلة
  2. 2
    An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

    المؤلفون: Jonas Mandel, Benoît Funalot, Laurent Magy, Odile Dubourg, Arnaud Lacour, Jean-Michel Vallat, Marie-Noëlle Lefebvre, Lamia Boudiaf, Marguerite Preudhomme, Mahmoud Al-Moussawi, Shahram Attarian, Daniel Cohen, Vincent Tiffreau, Pierre-Marie Gonnaud, Mickaël Guedj, Jérôme Franques, Rodolphe Hajj, Philippe Lehert, Jean Pouget, Catherine Scart-Grès, Armelle Magot, Yann Péréon, Ilya Chumakov, Walter Gilbert, Aude Milet, Laura Bossi, Tanya Stojkovic, Serguei Nabirotchkin, Karima Ghorab, Laurène Leclair-Visonneau, Viviane Bertrand, Joëlle Micallef

    المساهمون: UCL - SSH/ILSM - Louvain School of Management Research Institute

    المصدر: Orphanet Journal of Rare Diseases
    Orphanet Journal of Rare Diseases, Vol. 9, no.1, p. 199 (2014)

    مصطلحات موضوعية: Adult, Male, Baclofen, Charcot-Marie-Tooth, medicine.medical_specialty, Combination therapy, Pharmacology, Placebo, Phase 2, law.invention, Double-Blind Method, Randomized controlled trial, Charcot-Marie-Tooth Disease, law, Internal medicine, medicine, Clinical endpoint, Humans, Sorbitol, Genetics(clinical), Pharmacology (medical), Adverse effect, Wasting, Genetics (clinical), Medicine(all), business.industry, Research, General Medicine, Middle Aged, Naltrexone, Clinical trial, CMT1A, Tolerability, Drug Therapy, Combination, Female, Erratum, medicine.symptom, business, Repurposing

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d82998f2043b10469b1df30f30ed1b1Test
    https://doi.org/10.1186/s13023-014-0199-0Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث